Sigumir
Russian peptide bioregulator from cartilage tissue. Studied for joint cartilage preservation and osteoarthritis support in Khavinson longevity protocols.
0 anonymous reports
Also known as:
cartilage bioregulatorkhavinson jointsigumir peptide
browse topics:
community guides:
No reports found.
Community Q&A
- What is Sigumir used for?
- Community accounts describe Sigumir as the joint-targeted entry in the Russian bioregulator system — used specifically for cartilage health and joint function. Accounts from older users or those with joint conditions describe incorporating it into longevity stacks for osteoarthritis prevention and management. The most commonly cited subjective effects: reduced joint discomfort and improved mobility over multi-cycle annual protocols.
- How does Sigumir compare to BPC-157 for joints?
- Community accounts describe different mechanisms. BPC-157 accounts emphasise acute injury healing and local tissue repair; Sigumir accounts emphasise long-term cartilage preservation and chronic joint function support. Accounts that use both describe BPC-157 for acute joint injury and Sigumir as ongoing maintenance. Sigumir's oral capsule format versus BPC-157's injection is noted as a practical advantage for continuous use.